xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

619

Orlandi et al.

(Continues)

TABLE XII-22 Evidence for inert middle meatus stenting in sinus surgery Author Year LOE Study Design Study Groups Clinical Endpoint Conclusions Yaniv 2220 2019 2 RCT –Unilateral MM ST stent 2-4 weeks –Contralateral telfa pack 2 days –3-6- and 12- week endoscopic inflammation (VAS), MT adhesion, MTL –12 week SNOT-22 The ST stent is more effective than telfa packing in reducing sinonasal inflammation, MT adhesions, MTL, and SNOT-22 scores Manji 2213 2018 2 DBRCT, < 80%full follow-up –Unilateral MM silastic stent x 1week –Contralateral MM gloved merocel x 1 week –Patient pain with stent/packing removal at 1 week –5- and 12-week MLK score and synechia presence MM silastic is more painful to remove at 1 week than MM gloved merocele There is no difference in healing and synechia formation at 12 weeks between MM silastic stent and gloved merocel

reduce adhesions at 12 weeks

MM silastic splints do not significantly

change symptom or

endoscopic scores at 12weeks

effectively reduce

MTL, adhesions, and

crusting but have no effect on PROMs

MM silastic splints

MM silastic stents

–6- and 12- week ethmoid and synechia grading

–12-week symptom scores

–VAS 6 months

–MLK score 6 months

–Unilateral MM silastic stent x 2weeks

Chan 105 2015 2 DBRCT –Unilateral MM silastic stent x 2weeks Baguley 8 2012 2 RCT, < 80%full follow-up

–Contralateral MM no stent

–Contralateral MM no stent